Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC.

Clinical Briefings™: Optimizing Management of Patients With PID Disorders- Challenges and Opportunities in Diagnosis and Treatment

Access Activity

Overview / Abstract:

Target Audience
This activity is intended for allergists, immunologists, critical care specialists, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of PIDDs.

Program Overview
This online activity is designed to provide a concise and focused overview of the management of primary immune deficiency disorders (PIDDs), diagnostic evaluation of patients with these conditions, and the efficacy and safety of therapies recommended for the treatment of PIDDs. The multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Learning Objectives
Upon successful completion of this educational activity, you should be better prepared to:

Review the most prevalent types of PIDDs and their associated characteristics and disease burden
Discuss strategies for effective diagnosis of PIDDs to enable timely therapeutic intervention
Evaluate the efficacy and safety of IVIG and SCIG therapies for management of patients with PIDDs
Develop treatment strategies for special populations with PIDDs

Expiration

Jun 29, 2021

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Richard L. Wasserman, MD, PhD

Sponsors / Supporters / Grant Providers

Grifols

Keywords / Search Terms

Relias LLC Relias, Free CME, PID Disorders Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map